HomeInsightsStock Comparison

Alivus Life Sciences Ltd vs Sms Lifesciences India Ltd Stock Comparison

Alivus Life Sciences Ltd vs Sms Lifesciences India Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 1001 as of 01 Aug 15:30.
  • The P/E Ratio of Alivus Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of SMS Lifesciences India Ltd changed from 5.2 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 34.16% over 5 years.
  • The Market Cap of Alivus Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of SMS Lifesciences India Ltd changed from ₹ 52.91 crore on March 2020 to ₹ 205.21 crore on March 2024 . This represents a CAGR of 31.14% over 5 years.
  • The revenue of Alivus Life Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of SMS Lifesciences India Ltd for the Mar '25 is ₹ 91.45 crore as compare to the Dec '24 revenue of ₹ 84.66 crore. This represent the growth of 8.02%.
  • The ebitda of Alivus Life Sciences Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of SMS Lifesciences India Ltd for the Mar '25 is ₹ 9.76 crore as compare to the Dec '24 ebitda of ₹ 12.81 crore. This represent the decline of -23.81%.
  • The net profit of Alivus Life Sciences Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of SMS Lifesciences India Ltd changed from ₹ -3.83 crore to ₹ 3.48 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 58.56 % on March 2024 . This represents a CAGR of -1.60% over 3 yearsThe Dividend Payout of SMS Lifesciences India Ltd changed from 3.44 % on March 2021 to 3.47 % on March 2024 . This represents a CAGR of 0.22% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alivus Life Sciences Ltd

  • Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to 'Alivus Life Sciences Limited' on January 20, 2025. Nirma Limited is a Subsidiary of the Company.
  • The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business.

About SMS Lifesciences India Ltd

  • SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
  • The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
  • The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
  • The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

Alivus Life Sciences Ltd News Hub

News

Alivus Life Sciences to declare Quarterly Results

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 1 Aug...

Read more

25 Jul 2025 11:06

News

Board of Alivus Life Sciences recommends final dividend

Alivus Life Sciences announced that the Board of Directors of the Company at its meeting h...

Read more

16 May 2025 09:27

News

Alivus Life Sciences to hold board meeting

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 15 Ma...

Read more

09 May 2025 10:57

News

Alivus Life Sciences allots 92,096 equity shares under ESOS

Alivus Life Sciences has allotted 92,096 equity shares under ESOS on 30 April 2025. Conseq...

Read more

30 Apr 2025 19:38

News

Alivus Life jumps after Q3 PAT climbs 15% YoY to Rs 137 cr

Profit before tax (PBT) climbed 15.22% YoY to Rs 185.14 crore in Q3 FY25. For Q3FY25, EBIT...

Read more

23 Jan 2025 15:01

News

Alivus Life Sciences Ltd leads gainers in 'A' group

Avantel Ltd, Sunteck Realty Ltd, Spandana Sphoorty Financial Ltd and Jai Corp Ltd are amon...

Read more

21 Jan 2025 12:00

SMS Lifesciences India Ltd News Hub

News

SMS Lifesciences India Ltd leads gainers in 'B' group

Magellanic Cloud Ltd, Fischer Medical Ventures Ltd, Global Surfaces Ltd and 20 Microns Ltd...

Read more

16 Jul 2025 12:15

News

Board of SMS LifeSciences India recommends final dividend

SMS LifeSciences India announced that the Board of Directors of the Company at its meeting...

Read more

30 May 2025 11:19

News

SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 May 2025 11:21

News

SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr

Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a grow...

Read more

13 Feb 2025 12:51

News

SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

08 Feb 2025 16:22

News

SMS LifeSciences India to conduct board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 13 ...

Read more

09 Nov 2024 12:30

SWOT Analysis Of Alivus Life Sciences Ltd

Strength

2

S

Weakness

2

W

Opportunity

1

O

Threats

0

T

SWOT Analysis Of SMS Lifesciences India Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for SMS Lifesciences India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alivus Life Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alivus Life Sciences Ltd and SMS Lifesciences India Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or SMS Lifesciences India Ltd?

Market cap of Alivus Life Sciences Ltd is 12,278 Cr while Market cap of SMS Lifesciences India Ltd is 328 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and SMS Lifesciences India Ltd?

The stock performance of Alivus Life Sciences Ltd and SMS Lifesciences India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and SMS Lifesciences India Ltd?

As of August 2, 2025, the Alivus Life Sciences Ltd stock price is INR ₹1001.25. On the other hand, SMS Lifesciences India Ltd stock price is INR ₹1087.35.

How do dividend payouts of Alivus Life Sciences Ltd and SMS Lifesciences India Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and SMS Lifesciences India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions